CTA-Sticky-button.png clinicaltrialsyearbook+button

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

oncologytrialsEurope2017-heade.jpg

Protecting product pipeline and rising above competition through optimisation of operationally efficient, specifically targeted oncology clinical trials

5 & 6 December 2017, Munich, Germany

As the only operationally focussed oncology conference in Europe this two-day event is a must attend. After huge success in 2016, the Clinical Operations in Oncology Trials Europe Conference will be returning to Munich for its 4th edition, with more content and senior level speakers than ever before.

The 2017 programme will host speakers from the likes of Takeda Oncology, Bayer Healthcare, Roche, Medigene and PsiOxus Therapeutics.

Highlights for 2017 include an interactive panel discussion debating the benefits of partnering with Patient Advocacy Groups; a member of the EORTC discussing the advantages of oncology protocol designs; and spotlight sessions exploring what to consider when conducting a global oncology trial.

This conference provides a networking platform to discuss your top issues with your fellows, facilitating the formation of new partnerships and strengthening existing relationships.

CTO Europe will be returning on 5th & 6th December 2017 to Munich. Please get in touch if you are interested in taking part!

event+news+heading+long

4 Reasons to Attend CTO Europe 2017

Find out why this conference is an unmissable oncology event in Europe

Who should attend this event?

The Clinical Operations in Oncology Trials Europe event offers attendees the unique opportunity to debate and develop practical strategies that will enable their company, whether big or small, to improve their operational efficiency when conducting oncology clinical trials.

A CRO collaboration for oncology trials

Finding the right CRO for your oncology trial can be challenging, as CRO must have expertise specifically in cancer research. However, good collaboration with CRO can contribute to the success of your oncology trial. Smaller companies should also look into outsourcing as a realistic approach and ideally search for a CRO with Risk Based Monitoring (RBM) experience.

Patient recruitment: 4 challenges when it comes to oncology trials

Patient recruitment is challenging when it comes to clinical operations; but it’s even more troubling in oncology specific trials. This article will look at 4 obstacles that are common for patient recruitment and retention in oncology.

Countdown to Clinical Operations in Oncology Trials Europe 2017

ctoeurope_rotating_images.gif




300x250-Subscribe-for-updates-banner+version+2.jpg